Pay in 4 interest-free payments of $5.94 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
These medications have been extensively studied in large-scale clinical trials and are licensed by the MHRA for specific indications including type 2 diabetes and, in some cases, weight management, as outlined in NICE guidance (NG28)
Both medications represent major advances over previous pharmaceutical options
Long-Term Safety Considerations: While safety data from clinical trials spanning up to 24 weeks is reassuring, long-term safety data spanning years of continuous use remains limited
Recommended Dosing The starting dose of hydroxocobalamin for adults is 5 g administered as an intravenous infusion over 15 minutes (approximately 15 mL/min)
US$ 28.71
US$ 27.50
US$ 28.91
US$ 27.48
US$ 23.69
US$ 23.96
US$ 25.43
US$ 27.21
US$ 26.78
